Clolar and caecitis Patient Reports February 13, 2012

Clolar Side Effects Report #5914957-0
Clolar side effect was reported by a Physician from UNITED STATES on Oct 02, 2008. Male patient, child 9 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, caecitis, cardiac failure, coagulopathy, conjunctival haemorrhage. Clolar dosage: 73 MG, ONCE, INTRAVENOUS; 36.5 MG, QD, INTRAVENOUS. During the same period patient was treated with CYTARABINE, METHYLPREDNISOLONE, ALLOPURINOL, CEFEPIME, PERIDEX, MORPHINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5961452-9
Clolar side effect was reported by a Physician from UNITED STATES on Nov 11, 2008. Male patient, child 9 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, caecitis, cardiac failure, coagulopathy, conjunctival haemorrhage. Clolar dosage: 73 MG, ONCE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, METHYLPREDNISOLONE, ALLOPURINOL, CEFEPIME, PERIDEX, MORPHINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5973855-7
Clolar side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, child 10 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, caecitis, cardiac failure, coagulopathy, conjunctival haemorrhage. Clolar dosage: 73 MG, ONCE, INTRAVENOUS; 36.5 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCTARABINE, METHYLPREDNISOLONE, ALLOPURINOL, CEFEPIME, PERIDEX, MORPHINE. Patient was hospitalized and became disabled. Patient recovered.

Clolar Side Effects Report #6018769-1
Clolar side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Male patient, child 10 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, caecitis, cardiac failure, coagulopathy, conjunctival haemorrhage. Clolar dosage: 73 MG, ONCE, INTRAVENOUS; 36.5 MG. During the same period patient was treated with CYTARABINE, METHYLPREDNISOLONE, ALLOPURINOL, CEFEPIME, PERIDEX, MORPHINE. Patient was hospitalized and became disabled. Patient recovered.


Clolar Side Effects Report #6083355-4
Clolar side effect was reported by a Physician from UNITED STATES on Feb 04, 2009. Male patient, child 10 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: caecitis, candidiasis, cardiac failure, chloroma, circulatory collapse, coagulopathy, conjunctival haemorrhage, contusion, convulsion. Clolar dosage: 73 MG, ONCE; INTRAVENOUS; 36.5 MG, QD; INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ETOPOSIDE, METHYLPREDNISOLONE, ALLOPURINOL, CEFEPIME. Patient was hospitalized and became disabled. Patient died on 02/02/2009.

Clolar Side Effects Report #5590357-0
Clolar side effect was reported by a Physician from UNITED STATES on Jan 03, 2008. Male patient, 24 years of age, weighting 151.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: arthritis infective, caecitis, enterobacter infection, enterocolitis infectious, fungal infection , hypotension, post procedural complication, pseudomonas infection, sepsis . Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, GENTAMYCIN, NEURONTIN, MORPHINE, FLAGYL, MYCOSTATIN, VORICONAZOLE, ZOFRAN. Patient was hospitalized. Patient died on 12/15/2007.

Clolar Side Effects Report #4777766-4
Clolar side effect was reported by a Physician from UNITED STATES on Sept 08, 2005. Male patient, child 12 years of age, weighting 84.66 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: caecitis, chills, feeling abnormal, headache , herpes zoster, malaise, nausea , neuropathic pain. Clolar dosage: 52 MG/M2 QD IV. During the same period patient was treated with NEURONTIN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5578853-3
Clolar side effect was reported by a Physician from UNITED STATES on Dec 18, 2007. Male patient, 24 years of age, weighting 151.7 lb, was diagnosed with acute leukaemia, acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: aspiration joint abnormal, blood lactic acid increased, caecitis, culture positive, enterobacter infection, enterocolitis infectious, fungal infection , hypotension, joint swelling. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 12/15/2007.

Clolar Side Effects Report #5570303-6
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2007. Male patient, weighting 151.7 lb, was treated with Clolar. After drug was administered, patient experienced the following side effects: blood lactic acid increased, caecitis, colitis, enterobacter infection, enterococcal infection, fungal infection , hypotension, pseudomonas infection, refusal of treatment by relative. Clolar dosage: 73 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.